Interventional Spine, that has developed spinal implants that can be delivered percutaneously, raised $1.6 million by issuing debt. Here are the details:
Industry: Medical devices
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Location: Irvine, California
Solution/Product: The company makes several products for U.S. and overseas markets. Its most recent product is the FDA cleared PerX360° system that makes it possible to have a spinal fusion via two incisions that are less than 15 mm each. The procedure can be performed in 30 minutes.
Money Raised: $1.6 million out of a targeted $4 million
How it will be used: A call to the company’s CEO wasn’t immediately returned.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Investors: Investor information from the current round is unavailable, but these firms are represented on the company’s board – Rock Creek Capital, Wexford Capital LLC, HBM Partners.
Management team: Walter Cuevas, CEO; Jane Metcalf, VP of Quality, Clinical and Regualtory; Chris Warren, Director of R&D
Market: U.S. Sales of instrumented spinal fusion market and posterior dynamic stabilization procedures will rise to $2.79 billion in 2016, up from $2.40 billion in 2011., according to MedTech Insights.
